Preliminary data suggest a possible involvement of the melatonin MT1 but not MT2 receptor in the pathophysiology of bipolar disorder. The main objective of this short project is therefore to investigate at preclinical level whether the first selective MT1 receptor partial agonist to be synthesized (UCM871) can improve the bipolar symptomatology of the mice genetically […]
Read More